Skip to content

Grapevine Technologies Inc vs Medecule

Grapevine Technologies Inc logo

Grapevine Technologies Inc

Grapevine is the future of procurement. Our software helps medical practices cut their spending in half

25 employees · est. 2020 · New York, United States

VS
Medecule logo

Medecule

Simplifying institutional Procurement for Medical goods & Supplies

14 employees · est. 2015 · New Delhi, India

Medecule is the older company (2020 vs 2015).

Side-by-Side Comparison

Grapevine Technologies Inc Medecule
Founded
2020 2015 older
Headquarters
New York, United States New Delhi, India
Employees
25 14
Industry
Health Care, Supply Chain Health Care, Medical Devices
Funding Stage
Pre-Seed Not tracked yet
Total Funding
$2.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Pricing Negotiation, Vendor Network Expansion, Smart Rerouting, Workflow Optimization Not tracked yet
Target Customers
Medical Dermatologists, Oncology Specialists, Orthopedic Surgeons, Hospital Procurement Teams Not tracked yet
Taxonomy
Healthcare Supply ChainProcurement SoftwareMedical Supply OptimizationSupply Chain AutomationVendor ManagementAI-Driven Procurement +8 Medical ProcurementHealthcare SuppliesInstitutional ProcurementHospital EquipmentMedical Equipment SourcingRural Healthcare +7
Website
go-grapevine.com medecule.com
Grapevine Technologies Inc logo

About Grapevine Technologies Inc

Grapevine Technologies Inc, founded in 2020 and headquartered in the United States, is positioned at the intersection of Health Care and Supply Chain innovation. Their software platform is designed to overhaul the archaic healthcare supply chain, characterized by notorious inefficiencies and outdate...

Medecule logo

About Medecule

Medecule is a health care startup founded in 2015 in India. The company's slogan "Simplifying institutional Procurement for Medical goods & Supplies" encapsulates its core mission. This one-stop solution aims to cater to the procurement needs of hospitals and nursing homes, streamlining the process...

Also comparing in this category

Comparing more than these two?

Get Grapevine Technologies Inc, Medecule and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does Grapevine Technologies Inc compare?

A PDF of Grapevine Technologies Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

Grapevine Technologies Inc was founded in 2020, based in New York, United States, with 25 employees. Grapevine Technologies Inc, founded in 2020 and headquartered in the United States, is positioned at the intersection of Health Care and Supply Chain innovation. Their software platform is designed to. Medecule was founded in 2015, based in New Delhi, India, with 14 employees. Medecule is a health care startup founded in 2015 in India. The company's slogan "Simplifying institutional Procurement for Medical goods & Supplies" encapsulates its core mission. This one-stop solut.
Grapevine Technologies Inc has raised $2.00M and Medecule no disclosed funding. Latest stage: Grapevine Technologies Inc Pre-Seed.
Both work in Health Care and list healthcare supply chain among their focus areas.

Compare Grapevine Technologies Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Grapevine Technologies Inc on 24 Mar 2026, and Medecule on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout